Gosselies, Belgium, September 24th 2020 – Delphi Genetics announces today that it has obtained highly promising results with its Gene Therapy-based Covid-19 therapeutic candidate in in-vitro experiments.
With solid expertise in DNA development and production, Delphi Genetics has developed an innovative approach to treat patients infected by Covid-19.
The principle consists in inactivating and destroying the virus in cells where the virus is present. The main objective of this therapy is to cure the disease once patients get infected.
The company has three potential candidates, all three being tested with the collaboration of